Enabling precision medicine

President & CEO
"Whether supporting national genomics initiatives, enabling enterprise-scale laboratories, or helping smaller labs access advanced capabilities, our mission remains unchanged: to deliver clinical genomics software that laboratories can rely on. Today and for the long term."
Under Dr. Scherer's leadership, Golden Helix has grown from a bioinformatics research tool provider into a global leader in clinical genomics software, trusted by diagnostic labs, hospitals, and genome centers worldwide.
Golden Helix develops industry-leading clinical genomics software that empowers healthcare professionals and researchers to analyze and interpret NGS data with confidence. From variant analysis to clinical reporting, our platform supports the full diagnostic workflow.
We've helped hundreds of institutions across the globe adopt precision medicine, delivering tools that are powerful enough for the most complex analyses yet intuitive enough for teams at every level.
1998
Founded
400+
Institutions Worldwide
60+
Countries
1M+
Samples Analyzed
We stay committed to our core values across everything we build and every customer we serve.
Every feature we build is guided by its potential to improve patient outcomes and advance clinical genomics.
We push the boundaries of what's possible in genomic analysis, from AI-powered classification to integrated clinical workflows.
Our scientists and engineers work directly with customers, providing responsive, expert-level technical support.
With customers on every continent and a distribution partner in Japan, we serve the worldwide clinical genomics community.